These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 12223331
1. [The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy]. Göktekin O, Ritsushi K, Matsumoto K, Hiroshi M. Anadolu Kardiyol Derg; 2002 Sep; 2(3):226-30. PubMed ID: 12223331 [Abstract] [Full Text] [Related]
2. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. J Am Coll Cardiol; 2005 Mar 01; 45(5):697-704. PubMed ID: 15734613 [Abstract] [Full Text] [Related]
3. ST-segment depression as a risk factor in hypertrophic cardiomyopathy. Haghjoo M, Mohammadzadeh S, Taherpour M, Faghfurian B, Fazelifar AF, Alizadeh A, Rad MA, Sadr-Ameli MA. Europace; 2009 May 01; 11(5):643-9. PubMed ID: 19164362 [Abstract] [Full Text] [Related]
4. Pacing-induced increase in QT dispersion predicts sudden cardiac death following cardiac resynchronization therapy. Chalil S, Yousef ZR, Muyhaldeen SA, Smith RE, Jordan P, Gibbs CR, Leyva F. J Am Coll Cardiol; 2006 Jun 20; 47(12):2486-92. PubMed ID: 16781378 [Abstract] [Full Text] [Related]
5. Dispersion of QT interval in premature ventricular beats as a marker of susceptibility to arrhythmic events. Dabrowski A, Kramarz E, Piotrowicz R. J Cardiovasc Risk; 1998 Apr 20; 5(2):97-101. PubMed ID: 9821062 [Abstract] [Full Text] [Related]
6. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. Gimeno JR, Tomé-Esteban M, Lofiego C, Hurtado J, Pantazis A, Mist B, Lambiase P, McKenna WJ, Elliott PM. Eur Heart J; 2009 Nov 20; 30(21):2599-605. PubMed ID: 19689975 [Abstract] [Full Text] [Related]
8. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers]. Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L. Rev Esp Cardiol; 2006 Jun 20; 59(6):537-44. PubMed ID: 16790196 [Abstract] [Full Text] [Related]
9. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy]. Sadoul N, de Chillou C, Aliot E, McKenna WJ. Arch Mal Coeur Vaiss; 1999 Apr 20; 92 Spec No 1():65-73. PubMed ID: 10326160 [Abstract] [Full Text] [Related]
10. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy. Cotiga D, Ehlert F, Sherrid M. Anadolu Kardiyol Derg; 2006 Dec 20; 6 Suppl 2():55-60. PubMed ID: 17162272 [Abstract] [Full Text] [Related]
11. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?]. Grobéty M, Schlaepfer J, Kappenberger L, Fromer M. Schweiz Med Wochenschr; 1997 Apr 12; 127(15):623-30. PubMed ID: 9198888 [Abstract] [Full Text] [Related]
12. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Elliott PM, Gimeno JR, Tomé MT, Shah J, Ward D, Thaman R, Mogensen J, McKenna WJ. Eur Heart J; 2006 Aug 12; 27(16):1933-41. PubMed ID: 16754630 [Abstract] [Full Text] [Related]
13. QT interval dispersion analysis in patients with aortic valve stenosis: a prospective study. Orlowska-Baranowska E, Baranowski R, Zakrzewski D, Kusmierczyk B, Rawczynska-Englert I. J Heart Valve Dis; 2003 May 12; 12(3):319-24. PubMed ID: 12803331 [Abstract] [Full Text] [Related]
14. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications. Payá E, Marín F, González J, Gimeno JR, Feliu E, Romero A, Ruiz-Espejo F, Roldán V, Climent V, de la Morena G, Valdés M. J Card Fail; 2008 Jun 12; 14(5):414-9. PubMed ID: 18514934 [Abstract] [Full Text] [Related]
15. Sudden death in noncoronary heart disease is associated with delayed paced ventricular activation. Saumarez RC, Chojnowska L, Derksen R, Pytkowski M, Sterlinski M, Huang CL, Sadoul N, Hauer RN, Ruzyłło W, Grace AA. Circulation; 2003 May 27; 107(20):2595-600. PubMed ID: 12743006 [Abstract] [Full Text] [Related]
16. [Predictive value of QT interval dynamicity for sudden death in patients with idiopathic dilated cardiomyopathy]. Bao MW, Tan TT, Yu SB, Chen K, Huang CX. Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec 27; 38(12):1093-7. PubMed ID: 21215145 [Abstract] [Full Text] [Related]
17. [Characteristics of cardiac arrhythmia in patients with hypertrophic cardiomyopathy]. Wang Y, Cui YH, Wang DW. Zhonghua Yi Xue Za Zhi; 2004 Mar 02; 84(5):401-4. PubMed ID: 15061995 [Abstract] [Full Text] [Related]
18. [Sudden death during Holter electrocardiographic monitoring in a patient with hypertrophic cardiomyopathy]. Sato M, Takenaka K, Yamashita T, Koike S, Natori K, Nakahara K. J Cardiol; 1998 May 02; 31(5):297-303. PubMed ID: 9617660 [Abstract] [Full Text] [Related]
19. Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy. Leonardi S, Raineri C, De Ferrari GM, Ghio S, Scelsi L, Pasotti M, Tagliani M, Valentini A, Dore R, Raisaro A, Arbustini E. Eur Heart J; 2009 Aug 02; 30(16):2003-10. PubMed ID: 19474054 [Abstract] [Full Text] [Related]
20. [Dispersion of QT interval in arterial hypertension with left ventricular hypertrophy]. Cavallini B, Perri V, Sali M. Minerva Cardioangiol; 1996 Aug 02; 44(1-2):45-8. PubMed ID: 8767622 [Abstract] [Full Text] [Related] Page: [Next] [New Search]